These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11031710)

  • 1. Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D
    Kidney Blood Press Res; 2000; 23(3-5):163-6. PubMed ID: 11031710
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D
    J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membranous nephropathy. Insights from Heymann nephritis.
    Cavallo T
    Am J Pathol; 1994 Apr; 144(4):651-8. PubMed ID: 8160766
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to glomerular antigens.
    Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
    Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
    [No Abstract]   [Full Text] [Related]  

  • 7. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
    Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular pathogenesis of experimental membraneous glomerulonephritis (Heymann nephritis)].
    Kerjaschki D
    Pathologe; 1996 Jul; 17(4):262-8. PubMed ID: 8927592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp330 and RAP: the Heymann nephritis antigenic complex.
    Farquhar MG; Kerjaschki D; Lundstrom M; Orlando RA
    Ann N Y Acad Sci; 1994 Sep; 737():96-113. PubMed ID: 7944157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
    Makker SP
    J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unfolding story of megalin (gp330): now recognized as a drug receptor.
    Farquhar MG
    J Clin Invest; 1995 Sep; 96(3):1184. PubMed ID: 7657789
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
    Farquhar MG; Saito A; Kerjaschki D; Orlando RA
    J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heymann nephritis in Lewis rats.
    Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
    Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex.
    Orlando RA; Kerjaschki D; Kurihara H; Biemesderfer D; Farquhar MG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6698-702. PubMed ID: 1495959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.